Beta · prototype— This site is under construction: rankings, texts and features change every week.
UUback EN Follow the rankings Declare an interest

Index Ventures

Venture capital fund

Portfolio in 4 countries: 6 funded startups tracked by Uback, 6 of them in a ranking.

Portfolio on Uback6startups, 4 countries
In a ranking6ranked by AI-estimated valuation
On the Radar0eligible, not ranked
Latest deal trackedJul 2026Chai Discovery

Portfolio on Uback

Sorted by Uback rank, then Radar by last round
CompanyUbackSectorRound backedValuation (AI)
Alan#2 FranceInsurtech › health insuranceSeries G · USD 550M (EUR 480M) · Jun 2026Unicorn
Chai Discovery#1 AI drug discoveryHealthtech › Biotech › AI drug discoverySeries C · USD 400M · Jul 2026Unicorn
Cradle#12 AI drug discoveryHealthtech › Biotech › AI drug discoverySeries B · USD 73M · Nov 2024Hundreds of M$
Augment Code#12 Coding agentsArtificial intelligence › Agents › Coding agentsSeries B · USD 227M · Apr 2024Hundreds of M$
Pave#12 Talent managementBusiness software › HR › Talent managementSeries C · USD 100M · Jun 2022Hundreds of M$
Tessl#14 Coding agentsArtificial intelligence › Agents › Coding agentsSeries A · USD 100M · Nov 2024Hundreds of M$

Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.

By sector

Artificial intelligence2
Healthtech2
Business software1
Insurtech1

Deals tracked per year

12022
02023
32024
02025
22026

Co-investors

Prosus · Teachers' Venture Growth · Dara Holdings · Kleiner Perkins · Sequoia Capital · Dimension · IVP · Kindred Capital · Sutter Hill · Innovation Endeavors · Lightspeed · Accel · GV · boldstart

Investors that joined the same rounds, as reported by public sources.

Sources. augmentcode.com, cradle.bio, endpoints.news, european-biotechnology.com, finance.yahoo.com, prnewswire.com, techcrunch.com, thenextweb.com, as cited on each company’s profile.

Last updated: Sep 2026Report a missing dealReport an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.